BioCatalyst

PRAX — Praxis Precision Medicines, Inc. catalysts

2 verified catalyst event(s) for Praxis Precision Medicines, Inc. (ticker PRAX). Each is linked to its official source. Verified as of 2026-08-06.

Next verified catalyst

2026-12-01 — A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and P · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12 (month)
in 4mo
ESTIMATED
 READOUT
A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerabil
Phase 3 · Developmental and Epileptic Encephalopathy 1
 PRAX Praxis Precision Medicines, 1.0mg/kg/day PRAX-562, 1.5mg/kg/day PRAX ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
2026-12 (month)
in 4mo
ESTIMATED
 READOUT
A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Saf
Phase 3 · Epileptic Encephalopathy, SCN2A Encephalopathy
 PRAX Praxis Precision Medicines, 1mg elsunersen, 0.5mg elsunersen ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.